Results 101 to 110 of about 6,182,412 (149)

Long-term efficacy and safety of low-dose rituximab in immune thrombocytopenia: a multicentre, prospective, open-label, randomised controlled trial. [PDF]

open access: yesAnn Hematol
Chen Y   +17 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy